vs
GERON CORP（GERN）与万物新生（RERE）财务数据对比。点击上方公司名可切换其他公司
GERON CORP的季度营收约是万物新生的1.1倍（$47.2M vs $43.2M），万物新生净利率更高（16.9% vs -39.0%，领先55.9%）
杰龙公司是一家总部位于美国加利福尼亚州福斯特城的生物科技企业，专注于开发并商业化用于癌症治疗、可抑制端粒酶的治疗产品，深耕肿瘤治疗药物研发领域。
万物新生集团（ATRenew Inc.）是中国领先的二手消费电子产品交易与服务平台运营商，核心业务覆盖数码产品回收、质检、翻新及售卖，运营有爱回收等知名品牌，服务覆盖个人消费者及企业客户，市场遍及国内及部分东南亚地区。
GERN vs RERE — 直观对比
营收规模更大
GERN
是对方的1.1倍
$43.2M
净利率更高
RERE
高出55.9%
-39.0%
损益表 — Q3 FY2025 vs Q1 FY2023
| 指标 | | |
|---|---|---|
| 营收 | $47.2M | $43.2M |
| 净利润 | $-18.4M | $7.3M |
| 毛利率 | — | — |
| 营业利润率 | -29.4% | — |
| 净利率 | -39.0% | 16.9% |
| 营收同比 | 67.1% | — |
| 净利润同比 | 30.3% | — |
| 每股收益（稀释后） | $-0.03 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GERNRERE
| Q3 25 | $47.2M | — | ||
| Q2 25 | $49.0M | — | ||
| Q1 25 | $39.6M | — | ||
| Q3 24 | $28.3M | — | ||
| Q2 24 | $882.0K | — | ||
| Q1 24 | $304.0K | — | ||
| Q4 23 | $23.0K | — | ||
| Q3 23 | $164.0K | — |
净利润GERNRERE
| Q3 25 | $-18.4M | — | ||
| Q2 25 | $-16.4M | — | ||
| Q1 25 | $-19.8M | — | ||
| Q3 24 | $-26.4M | — | ||
| Q2 24 | $-67.4M | — | ||
| Q1 24 | $-55.4M | — | ||
| Q4 23 | — | — | ||
| Q3 23 | $-44.8M | — |
营业利润率GERNRERE
| Q3 25 | -29.4% | — | ||
| Q2 25 | -25.4% | — | ||
| Q1 25 | -42.2% | — | ||
| Q3 24 | -99.8% | — | ||
| Q2 24 | -7860.9% | — | ||
| Q1 24 | -18465.1% | — | ||
| Q4 23 | — | — | ||
| Q3 23 | -29031.7% | — |
净利率GERNRERE
| Q3 25 | -39.0% | — | ||
| Q2 25 | -33.4% | — | ||
| Q1 25 | -50.1% | — | ||
| Q3 24 | -93.5% | — | ||
| Q2 24 | -7639.8% | — | ||
| Q1 24 | -18220.4% | — | ||
| Q4 23 | — | — | ||
| Q3 23 | -27320.1% | — |
每股收益（稀释后）GERNRERE
| Q3 25 | $-0.03 | — | ||
| Q2 25 | $-0.02 | — | ||
| Q1 25 | $-0.03 | — | ||
| Q3 24 | $-0.04 | — | ||
| Q2 24 | $-0.10 | — | ||
| Q1 24 | $-0.09 | — | ||
| Q4 23 | — | — | ||
| Q3 23 | $-0.08 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $78.1M | $228.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $248.7M | $557.1M |
| 总资产 | $567.4M | $722.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资GERNRERE
| Q3 25 | $78.1M | — | ||
| Q2 25 | $77.7M | — | ||
| Q1 25 | $83.7M | — | ||
| Q3 24 | $60.3M | — | ||
| Q2 24 | $116.9M | — | ||
| Q1 24 | $189.8M | — | ||
| Q4 23 | $70.0M | — | ||
| Q3 23 | $30.7M | — |
股东权益GERNRERE
| Q3 25 | $248.7M | — | ||
| Q2 25 | $259.5M | — | ||
| Q1 25 | $268.2M | — | ||
| Q3 24 | $292.3M | — | ||
| Q2 24 | $306.7M | — | ||
| Q1 24 | $344.9M | — | ||
| Q4 23 | $247.9M | — | ||
| Q3 23 | $290.6M | — |
总资产GERNRERE
| Q3 25 | $567.4M | — | ||
| Q2 25 | $555.2M | — | ||
| Q1 25 | $562.5M | — | ||
| Q3 24 | $444.9M | — | ||
| Q2 24 | $449.4M | — | ||
| Q1 24 | $482.1M | — | ||
| Q4 23 | $394.1M | — | ||
| Q3 23 | $413.0M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-13.6M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流GERNRERE
| Q3 25 | $-13.6M | — | ||
| Q2 25 | $-27.4M | — | ||
| Q1 25 | $-48.0M | — | ||
| Q3 24 | $-58.9M | — | ||
| Q2 24 | $-53.5M | — | ||
| Q1 24 | $-62.3M | — | ||
| Q4 23 | $-167.7M | — | ||
| Q3 23 | $-50.8M | — |
自由现金流GERNRERE
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-53.7M | — | ||
| Q1 24 | $-62.9M | — | ||
| Q4 23 | $-168.6M | — | ||
| Q3 23 | $-51.0M | — |
自由现金流率GERNRERE
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -6086.6% | — | ||
| Q1 24 | -20680.3% | — | ||
| Q4 23 | -732926.1% | — | ||
| Q3 23 | -31116.5% | — |
资本支出强度GERNRERE
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 23.4% | — | ||
| Q1 24 | 202.3% | — | ||
| Q4 23 | 3608.7% | — | ||
| Q3 23 | 117.1% | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
